newsfilter
← Latest News
PR Newswire·

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...